Stability indicating studies on NMITLI 118RT+ (standardized extract of withania somnifera dunal)

por Ahmad, Hafsa, Khandelwal, Kiran, Pachauri, Shakti Deep, Sanghwan, Rajender Singh, Dwivedi, Anil Kumar
Publicado 2014

In Silico and In Vitro Anticancer Activity of Isolated Novel Marker Compound from Chemically Modified Bioactive Fraction from Curcuma longa (NCCL)

por Naqvi, Arshi, Malasoni, Richa, Gupta, Swati, Srivastava, Akansha, Pandey, Rishi R., Dwivedi, Anil Kumar
Publicado 2017

Assay method for quality control and stability studies of a new antimalarial agent (CDRI 99/411)()

por Khandelwal, Kiran, Pachauri, Shakti Deep, Zaidi, Sofia, Dwivedi, Pankaj, Sharma, Ashok Kumar, Singh, Chandan, Dwivedi, Anil Kumar
Publicado 2013

Assay method for quality control and stability studies of a new anti-diabetic and anti-dyslipidemic flavone (S002-853)*

por Naqvi, Arshi, Pandey, Anuja, Gupta, Varsha, Malasoni, Richa, Srivastava, Akansha, Pandey, Rishi Ranjan, Satyanarayana, M., Pratap, Ram, Dwivedi, Anil Kumar
Publicado 2015

Curcuma oil ameliorates insulin resistance & associated thrombotic complications in hamster & rat

por Singh, Vishal, Jain, Manish, Misra, Ankita, Khanna, Vivek, Prakash, Prem, Malasoni, Richa, Dwivedi, Anil Kumar, Dikshit, Madhu, Barthwal, Manoj Kumar
Publicado 2015

S-Enantiomer of the Antitubercular Compound S006-830 Complements Activity of Frontline TB Drugs and Targets Biogenesis of Mycobacterium tuberculosis Cell Envelope

por Singh, Padam, Kumar, Shashi Kant, Maurya, Vineet Kumar, Mehta, Basant Kumar, Ahmad, Hafsa, Dwivedi, Anil Kumar, Chaturvedi, Vinita, Thakur, Tejender S., Sinha, Sudhir
Publicado 2017

Correction to “S-Enantiomer of the Antitubercular Compound S006-830 Complements Activity of Frontline TB Drugs and Targets Biogenesis of Mycobacterium tuberculosis Cell Envelope”...

por Singh, Padam, Kumar, Shashi Kant, Maurya, Vineet Kumar, Mehta, Basant Kumar, Ahmad, Hafsa, Dwivedi, Anil Kumar, Chaturvedi, Vinita, Thakur, Tejender S., Sinha, Sudhir
Publicado 2017